{"id":4002,"date":"2023-10-03T13:14:24","date_gmt":"2023-10-03T13:14:24","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/"},"modified":"2026-01-22T17:08:07","modified_gmt":"2026-01-22T17:08:07","slug":"establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/","title":{"rendered":"Establishing assays to investigate combinations of fractioned radiotherapy with DNA damage response agents in vitro and in vivo to enable investigation of radiosensitisation and improved anti-tumour responses."},"content":{"rendered":"

Radiotherapy is the main treatment modality for multiple cancer types, with approximately half of all cancer patients receiving radiotherapy as part of their treatment regimen. In addition to direct cytotoxic effects on cancer cells<\/a>, it is now appreciated that radiosensitisation using specific drugs targeting DNA damage response (DDR) pathways can enhance the sensitivity of tissues or cells to radiation therapy.\u00a0 Establishing assays to screen for potential radiosensitising compounds is therefore valuable to inform drug discovery research.<\/p>\n

At Sygnature Discovery, we have recently validated the in vitro<\/em> and in vivo<\/em> methodology to screen for potential radiosensitising compounds using the MDA-MB-436 human breast cancer cell line. Inhibitors of DNA-dependent protein kinase (DNA-PK) (AZD7648) or Poly-(ADP-Ribose)-Polymerase (PARP) (Niraparib) were used as tool radiosensitizing compounds, as these proteins play key roles in the repair of radiation-induced DNA double-strand breaks. Effects on cell viability, cell cycle progression and DDR biomarkers were determined under a variety of irradiation (IR) and compound conditions.\u00a0 In parallel, an in vivo <\/em>efficacy study was performed.<\/p>\n","protected":false},"excerpt":{"rendered":"

Radiotherapy is a cornerstone in treating various cancer types, and enhancing its effectiveness through radiosensitization has gained importance. At Sygnature Discovery, we’ve recently validated innovative in vitro and in vivo methods for screening potential radiosensitizing compounds. Our assays using the MDA-MB-436 human breast cancer cell line, along with inhibitors targeting DNA damage response pathways, provide valuable insights into improving cancer treatment. Discover more about our research in this critical field.<\/p>\n","protected":false},"featured_media":2670,"template":"","category":[685,751,738,688],"class_list":["post-4002","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-in-vivo-pharmacology","category-oncology","category-oncology-models","category-therapeutic-areas"],"acf":[],"yoast_head":"\nValidated Assays for Potential Radiosensitizing Compounds<\/title>\n<meta name=\"description\" content=\"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Validated Assays for Potential Radiosensitizing Compounds\" \/>\n<meta property=\"og:description\" content=\"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T17:08:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png\" \/>\n\t<meta property=\"og:image:width\" content=\"888\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/\",\"name\":\"Validated Assays for Potential Radiosensitizing Compounds\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png\",\"datePublished\":\"2023-10-03T13:14:24+00:00\",\"dateModified\":\"2026-01-22T17:08:07+00:00\",\"description\":\"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png\",\"width\":888,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Establishing assays to investigate combinations of fractioned radiotherapy with DNA damage response agents in vitro and in vivo to enable investigation of radiosensitisation and improved anti-tumour responses.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Validated Assays for Potential Radiosensitizing Compounds","description":"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/","og_locale":"fr_CA","og_type":"article","og_title":"Validated Assays for Potential Radiosensitizing Compounds","og_description":"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T17:08:07+00:00","og_image":[{"width":888,"height":628,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/","name":"Validated Assays for Potential Radiosensitizing Compounds","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png","datePublished":"2023-10-03T13:14:24+00:00","dateModified":"2026-01-22T17:08:07+00:00","description":"Explore our validated assays for potential radiosensitizing compounds in radiotherapy research. Download our digital poster to learn more.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Poster_A0-Landscape_IR-DDRi_AACR-NCI-EORTC-e1744810532159.png","width":888,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/establishing-assays-to-investigate-combinations-of-fractioned-radiotherapy-with-dna-damage-response-agents-in-vitro-and-in-vivo-to-enable-investigation-of-radiosensitisation-and-improved-anti-tumour-r\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Establishing assays to investigate combinations of fractioned radiotherapy with DNA damage response agents in vitro and in vivo to enable investigation of radiosensitisation and improved anti-tumour responses."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4002\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2670"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=4002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=4002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}